Premium
Polypodium leucotomos inhibits ultraviolet B radiation‐induced immunosuppression
Author(s) -
Siscovick Jonathan R.,
Zapolanski Tamar,
Magro Cynthia,
Carrington Kristel,
Prograis Shan,
Nussbaum Marnie,
Gonzalez Salvador,
Ding Wanhong,
Granstein Richard D.
Publication year - 2008
Publication title -
photodermatology, photoimmunology and photomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.736
H-Index - 60
eISSN - 1600-0781
pISSN - 0905-4383
DOI - 10.1111/j.1600-0781.2008.00352.x
Subject(s) - immunosuppression , oxazolone , immune system , skin cancer , ultraviolet b radiation , ultraviolet b , pharmacology , immunology , medicine , chemistry , ultraviolet radiation , cancer research , cancer , dermatology , radiochemistry
Summary Background: An extract of the tropical fern Polypodium leucotomos (PL) administered orally to mice inhibits ultraviolet B (UVB) radiation‐induced skin cancer formation. UVB‐induced murine skin cancers occur, in part, because of UVB‐induced immunosuppression. Thus, we examined whether PL inhibits UVB‐suppression of the induction of contact hypersensitivity (CHS) locally or systemically. Methods: C57BL/6 mice received standard drinking water or water‐containing PL. In the local model, mice were shaved on the dorsum and exposed to 3500 J/m 2 of UVB radiation daily for 4 days. Control mice were not irradiated. After the last irradiation they were sensitized to oxazolone topically at the irradiated site. To examine the ability of PL to inhibit systemic UVB‐induced immunosuppression, mice were given 10 000 J/m 2 of UVB radiation once and immunized at a non‐exposed site 3 days later. Six days after immunization (in both models), mice were challenged on the ears with oxazolone and 24/48 h ear swelling assessed. Results: PL in drinking water significantly reduced the inhibition of CHS observed with exposure to UVB radiation in both the local and systemic models. Conclusions: The ability of PL to inhibit UVB radiation‐induced immune suppression may explain, in part, its ability to inhibit UVR‐induced skin cancer induction in mice.